Skip to main content

Table 3 Type of uterotonic used for AMTSL by level of health facility

From: Improvement in the active management of the third stage of labor for the prevention of postpartum hemorrhage in Tanzania: a cross-sectional study

Uterotonic type

Hospitals n (%)

Health centers & dispensaries n (%)

All health facilities n (%)

2010 (N = 164)

2012 (N = 283)

% point change

p value

2010 (N = 239)

2012 (N = 168)

% point change

p value

2010 (N = 403)

2012 (N = 451)

% point change

p value

Oxytocin

164 (100)

282 (99.7)

−0.3

0.482

139 (58.1)

160 (95.2)

37.1

< 0.001

303 (75.2)

442 (98.0)

22.8

< 0.001

Ergometrine

0 (0)

0 (0)

0

-

74 (31.0)

8 (4.8)

−26.2

< 0.001

74 (18.4)

8 (1.8)

−16.6

< 0.001

Misoprostol

0 (0)

1 (0.4)

0.4

0.27

26 (10.9)

0 (0)

−10.9

< 0.001

26 (6.4)

1 (0.2)

−6.2

< 0.001

  1. N number of deliveries; n frequency